GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 59 filers reported holding GT BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 1.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,917 | -22.7% | 20,395 | 0.0% | 0.00% | – |
| Q2 2023 | $6,363 | -49.5% | 20,395 | -10.9% | 0.00% | – |
| Q1 2023 | $12,592 | -33.6% | 22,895 | +7.0% | 0.00% | -100.0% |
| Q4 2022 | $18,950 | -50.1% | 21,395 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $38,000 | -40.6% | 21,395 | -0.0% | 0.00% | -50.0% |
| Q2 2022 | $64,000 | +3.2% | 21,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $62,000 | – | 21,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baskin Financial Services Inc. | 151,354 | $47 | 0.01% |
| McCollum Christoferson Group LLC | 17,500 | $5,460 | 0.00% |
| Moss Adams Wealth Advisors LLC | 10,000 | $3,120 | 0.00% |
| JANE STREET GROUP, LLC | 20,501 | $6,396 | 0.00% |
| Cubist Systematic Strategies, LLC | 10,458 | $3,263 | 0.00% |
| Point72 Asset Management, L.P. | 1 | $0 | 0.00% |
| UBS Group AG | 3,033 | $946 | 0.00% |
| Compagnie Lombard Odier SCmA | 50,000 | $15,600 | 0.00% |
| IFP Advisors, Inc | 100 | $275 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,017 | $316 | 0.00% |